| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Microwaves | 3 | 2018 | 88 | 2.05 | Why? |
| Embolization, Therapeutic | 5 | 2021 | 269 | 1.89 | Why? |
| Endoleak | 2 | 2018 | 16 | 1.45 | Why? |
| Radiography, Interventional | 7 | 2020 | 158 | 1.34 | Why? |
| Central Venous Catheters | 2 | 2020 | 188 | 1.29 | Why? |
| Stents | 6 | 2019 | 916 | 1.22 | Why? |
| Liver Neoplasms | 6 | 2020 | 1666 | 1.16 | Why? |
| Diffusion Magnetic Resonance Imaging | 2 | 2018 | 317 | 1.15 | Why? |
| Catheter Ablation | 3 | 2018 | 438 | 1.11 | Why? |
| Catheterization, Central Venous | 2 | 2020 | 458 | 1.05 | Why? |
| Ureteral Obstruction | 2 | 2017 | 61 | 0.99 | Why? |
| Carcinoma, Hepatocellular | 4 | 2020 | 1222 | 0.90 | Why? |
| Kidney Neoplasms | 3 | 2018 | 832 | 0.87 | Why? |
| Prosthesis Implantation | 2 | 2017 | 261 | 0.85 | Why? |
| Chemoembolization, Therapeutic | 2 | 2018 | 144 | 0.83 | Why? |
| Cone-Beam Computed Tomography | 2 | 2017 | 118 | 0.82 | Why? |
| Ultrasonography, Doppler, Duplex | 2 | 2021 | 168 | 0.82 | Why? |
| Angiography | 2 | 2020 | 301 | 0.78 | Why? |
| Angiomyolipoma | 1 | 2018 | 11 | 0.78 | Why? |
| Venae Cavae | 1 | 2018 | 3 | 0.77 | Why? |
| Paraganglioma, Extra-Adrenal | 1 | 2018 | 8 | 0.76 | Why? |
| Retroperitoneal Neoplasms | 1 | 2018 | 17 | 0.75 | Why? |
| Enbucrilate | 1 | 2018 | 7 | 0.75 | Why? |
| Ablation Techniques | 1 | 2018 | 54 | 0.74 | Why? |
| Device Removal | 2 | 2018 | 221 | 0.74 | Why? |
| Polyvinyls | 1 | 2018 | 23 | 0.74 | Why? |
| Pelvic Neoplasms | 1 | 2018 | 25 | 0.72 | Why? |
| Parotid Neoplasms | 1 | 2018 | 29 | 0.71 | Why? |
| Ureter | 1 | 2017 | 59 | 0.69 | Why? |
| Leiomyoma | 1 | 2018 | 59 | 0.68 | Why? |
| Constriction, Pathologic | 1 | 2018 | 212 | 0.67 | Why? |
| Hospital Design and Construction | 1 | 2020 | 287 | 0.67 | Why? |
| Coronary Restenosis | 1 | 2019 | 153 | 0.67 | Why? |
| Veins | 1 | 2018 | 168 | 0.66 | Why? |
| Hospitals, Isolation | 1 | 2020 | 300 | 0.64 | Why? |
| Image Enhancement | 1 | 2018 | 177 | 0.62 | Why? |
| Aortic Aneurysm | 1 | 2017 | 121 | 0.59 | Why? |
| Endovascular Procedures | 4 | 2018 | 1302 | 0.59 | Why? |
| Neuroendocrine Tumors | 1 | 2018 | 241 | 0.57 | Why? |
| Reoperation | 1 | 2017 | 544 | 0.57 | Why? |
| Lymphadenopathy | 1 | 2021 | 444 | 0.56 | Why? |
| Gastrointestinal Hemorrhage | 1 | 2021 | 669 | 0.56 | Why? |
| Neovascularization, Pathologic | 1 | 2018 | 305 | 0.55 | Why? |
| Radiology Department, Hospital | 1 | 2020 | 805 | 0.46 | Why? |
| Venous Thrombosis | 3 | 2021 | 2739 | 0.43 | Why? |
| Thorax | 4 | 2021 | 1873 | 0.41 | Why? |
| Carcinoma, Renal Cell | 1 | 2017 | 545 | 0.41 | Why? |
| Magnetic Resonance Imaging | 5 | 2021 | 6551 | 0.40 | Why? |
| Vascular Diseases | 1 | 2018 | 846 | 0.38 | Why? |
| Tomography, X-Ray Computed | 17 | 2021 | 25144 | 0.37 | Why? |
| Nephrostomy, Percutaneous | 1 | 2007 | 13 | 0.35 | Why? |
| Ureteral Neoplasms | 1 | 2007 | 34 | 0.34 | Why? |
| Radiography, Thoracic | 3 | 2021 | 5486 | 0.34 | Why? |
| Catheterization | 2 | 2007 | 264 | 0.34 | Why? |
| Radiology, Interventional | 4 | 2020 | 398 | 0.34 | Why? |
| Treatment Outcome | 19 | 2019 | 51732 | 0.33 | Why? |
| Point-of-Care Testing | 1 | 2020 | 2782 | 0.33 | Why? |
| Neoplasms | 3 | 2020 | 17251 | 0.30 | Why? |
| Iliac Artery | 2 | 2017 | 50 | 0.27 | Why? |
| Prostatic Neoplasms | 1 | 2017 | 1637 | 0.27 | Why? |
| Multidetector Computed Tomography | 2 | 2019 | 307 | 0.27 | Why? |
| Immunotherapy | 1 | 2017 | 2421 | 0.26 | Why? |
| Medical Oncology | 1 | 2020 | 3826 | 0.26 | Why? |
| Blood Vessel Prosthesis Implantation | 2 | 2018 | 226 | 0.26 | Why? |
| Hypoxia | 1 | 2018 | 3626 | 0.25 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.24 | Why? |
| Liver Transplantation | 1 | 2018 | 2864 | 0.24 | Why? |
| Clinical Chemistry Tests | 1 | 2021 | 82 | 0.21 | Why? |
| Computed Tomography Angiography | 3 | 2020 | 2153 | 0.21 | Why? |
| Humans | 56 | 2021 | 930598 | 0.21 | Why? |
| Male | 32 | 2021 | 367725 | 0.20 | Why? |
| Densitometry | 1 | 2019 | 40 | 0.20 | Why? |
| Thoracic Injuries | 2 | 2017 | 63 | 0.20 | Why? |
| Aged | 24 | 2021 | 215776 | 0.20 | Why? |
| Supervised Machine Learning | 1 | 2021 | 172 | 0.19 | Why? |
| Uterine Artery Embolization | 1 | 2018 | 6 | 0.19 | Why? |
| Tuberous Sclerosis | 1 | 2018 | 63 | 0.19 | Why? |
| Arteries | 1 | 2021 | 283 | 0.18 | Why? |
| Aortography | 1 | 2018 | 60 | 0.18 | Why? |
| Retroperitoneal Space | 1 | 2018 | 68 | 0.18 | Why? |
| Precision Medicine | 2 | 2019 | 1477 | 0.18 | Why? |
| Rib Cage | 1 | 2017 | 15 | 0.18 | Why? |
| Portal Vein | 1 | 2020 | 193 | 0.18 | Why? |
| Brachiocephalic Veins | 1 | 2017 | 5 | 0.18 | Why? |
| Testicular Neoplasms | 1 | 2019 | 91 | 0.18 | Why? |
| Neoplasms, Germ Cell and Embryonal | 1 | 2019 | 106 | 0.18 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.18 | Why? |
| Solitary Pulmonary Nodule | 1 | 2019 | 83 | 0.18 | Why? |
| Italy | 7 | 2021 | 38444 | 0.17 | Why? |
| Radiotherapy, Image-Guided | 1 | 2018 | 77 | 0.17 | Why? |
| Fluoroscopy | 1 | 2017 | 140 | 0.17 | Why? |
| Disease Transmission, Infectious | 2 | 2020 | 9044 | 0.17 | Why? |
| Image-Guided Biopsy | 1 | 2019 | 185 | 0.17 | Why? |
| Balloon Occlusion | 1 | 2017 | 39 | 0.17 | Why? |
| Quality of Life | 1 | 2018 | 9820 | 0.17 | Why? |
| Pelvis | 1 | 2018 | 125 | 0.17 | Why? |
| Subclavian Vein | 1 | 2017 | 32 | 0.17 | Why? |
| Jugular Veins | 1 | 2017 | 52 | 0.16 | Why? |
| Microspheres | 1 | 2018 | 261 | 0.16 | Why? |
| Disposable Equipment | 1 | 2020 | 332 | 0.16 | Why? |
| Female | 27 | 2021 | 380317 | 0.16 | Why? |
| Sneddon Syndrome | 1 | 2015 | 2 | 0.16 | Why? |
| Hematologic Tests | 1 | 2021 | 521 | 0.16 | Why? |
| Respiratory Rate | 1 | 2020 | 691 | 0.16 | Why? |
| Postpartum Hemorrhage | 1 | 2017 | 144 | 0.15 | Why? |
| Mammary Arteries | 1 | 2015 | 31 | 0.15 | Why? |
| Ultrasonography, Doppler | 1 | 2019 | 406 | 0.15 | Why? |
| Middle Aged | 22 | 2021 | 270681 | 0.15 | Why? |
| Aortic Aneurysm, Thoracic | 1 | 2018 | 161 | 0.15 | Why? |
| Foreign Bodies | 1 | 2018 | 171 | 0.14 | Why? |
| Vascular System Injuries | 1 | 2016 | 91 | 0.14 | Why? |
| Placenta Diseases | 1 | 2017 | 180 | 0.14 | Why? |
| Aged, 80 and over | 11 | 2020 | 88759 | 0.14 | Why? |
| Bone Neoplasms | 1 | 2018 | 287 | 0.14 | Why? |
| Prosthesis Design | 1 | 2017 | 594 | 0.14 | Why? |
| Surgery, Computer-Assisted | 1 | 2017 | 183 | 0.14 | Why? |
| Catheterization, Peripheral | 1 | 2018 | 249 | 0.14 | Why? |
| Early Diagnosis | 2 | 2020 | 2443 | 0.14 | Why? |
| Aneurysm | 1 | 2015 | 117 | 0.13 | Why? |
| Cholangiocarcinoma | 1 | 2016 | 186 | 0.13 | Why? |
| Retrospective Studies | 10 | 2021 | 105322 | 0.13 | Why? |
| Bile Duct Neoplasms | 1 | 2016 | 172 | 0.13 | Why? |
| Symptom Flare Up | 1 | 2017 | 432 | 0.13 | Why? |
| Ultrasonography | 2 | 2020 | 4409 | 0.13 | Why? |
| Wounds, Nonpenetrating | 1 | 2016 | 157 | 0.13 | Why? |
| Radiography | 2 | 2020 | 1576 | 0.13 | Why? |
| Neoplasm Staging | 2 | 2019 | 1999 | 0.13 | Why? |
| Aneurysm, Dissecting | 1 | 2018 | 303 | 0.13 | Why? |
| Spleen | 1 | 2017 | 877 | 0.13 | Why? |
| Diagnostic Imaging | 2 | 2019 | 1044 | 0.12 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.12 | Why? |
| Personal Protective Equipment | 4 | 2020 | 15978 | 0.12 | Why? |
| Patient Selection | 1 | 2007 | 4560 | 0.12 | Why? |
| Lung | 3 | 2020 | 31049 | 0.12 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.12 | Why? |
| Image Processing, Computer-Assisted | 2 | 2018 | 1383 | 0.12 | Why? |
| Blood Vessel Prosthesis | 2 | 2015 | 115 | 0.12 | Why? |
| Adenocarcinoma | 1 | 2019 | 651 | 0.11 | Why? |
| Pre-Exposure Prophylaxis | 1 | 2021 | 1138 | 0.11 | Why? |
| Coronavirus | 1 | 2021 | 18339 | 0.11 | Why? |
| Contrast Media | 1 | 2018 | 1011 | 0.11 | Why? |
| Ferritins | 1 | 2020 | 2055 | 0.11 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2021 | 1731 | 0.11 | Why? |
| Image Interpretation, Computer-Assisted | 1 | 2018 | 665 | 0.11 | Why? |
| Positive-Pressure Respiration | 1 | 2019 | 1160 | 0.11 | Why? |
| Fluorodeoxyglucose F18 | 1 | 2019 | 1153 | 0.11 | Why? |
| Equipment Contamination | 1 | 2020 | 1308 | 0.11 | Why? |
| Personnel Staffing and Scheduling | 1 | 2020 | 1578 | 0.11 | Why? |
| Adult | 13 | 2021 | 244371 | 0.11 | Why? |
| Workflow | 1 | 2020 | 2373 | 0.11 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.10 | Why? |
| Pandemics | 10 | 2020 | 389249 | 0.10 | Why? |
| Intensive Care Units | 3 | 2020 | 29594 | 0.09 | Why? |
| Diagnosis, Differential | 3 | 2019 | 7220 | 0.09 | Why? |
| Positron Emission Tomography Computed Tomography | 1 | 2019 | 1458 | 0.09 | Why? |
| Combined Modality Therapy | 1 | 2018 | 3395 | 0.09 | Why? |
| Urography | 1 | 2007 | 4 | 0.09 | Why? |
| Incidence | 2 | 2020 | 25622 | 0.09 | Why? |
| Equipment Design | 1 | 2019 | 3095 | 0.09 | Why? |
| Hydronephrosis | 1 | 2007 | 28 | 0.09 | Why? |
| Prospective Studies | 5 | 2020 | 43301 | 0.09 | Why? |
| Fibrin Fibrinogen Degradation Products | 2 | 2020 | 5993 | 0.08 | Why? |
| Heparin | 1 | 2020 | 2600 | 0.08 | Why? |
| Oxygen | 1 | 2020 | 3715 | 0.08 | Why? |
| Liver | 2 | 2018 | 4007 | 0.08 | Why? |
| Reproducibility of Results | 2 | 2018 | 11304 | 0.08 | Why? |
| Placenta | 1 | 2017 | 1531 | 0.08 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.08 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.08 | Why? |
| Point-of-Care Systems | 1 | 2019 | 2955 | 0.08 | Why? |
| Arterial Occlusive Diseases | 1 | 2010 | 363 | 0.08 | Why? |
| Superior Vena Cava Syndrome | 1 | 2005 | 26 | 0.07 | Why? |
| Predictive Value of Tests | 2 | 2018 | 9537 | 0.07 | Why? |
| Artificial Intelligence | 1 | 2020 | 3543 | 0.07 | Why? |
| Algorithms | 2 | 2020 | 7346 | 0.07 | Why? |
| Neuroaspergillosis | 1 | 2003 | 5 | 0.07 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.07 | Why? |
| Venous Thromboembolism | 2 | 2021 | 4273 | 0.06 | Why? |
| Enoxaparin | 2 | 2021 | 1064 | 0.06 | Why? |
| Behcet Syndrome | 1 | 2005 | 136 | 0.06 | Why? |
| Disease Management | 2 | 2019 | 6841 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2018 | 3550 | 0.06 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.06 | Why? |
| Sensitivity and Specificity | 2 | 2020 | 22971 | 0.06 | Why? |
| Lung Neoplasms | 1 | 2019 | 3228 | 0.06 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.06 | Why? |
| Immunologic Factors | 1 | 2017 | 4206 | 0.05 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.05 | Why? |
| Anticoagulants | 2 | 2020 | 9563 | 0.05 | Why? |
| Feasibility Studies | 2 | 2021 | 3467 | 0.05 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.05 | Why? |
| Seminoma | 1 | 2019 | 16 | 0.05 | Why? |
| Thrombectomy | 1 | 2010 | 2272 | 0.05 | Why? |
| Vascular Surgical Procedures | 1 | 2008 | 882 | 0.05 | Why? |
| Health Care Costs | 1 | 2007 | 1007 | 0.05 | Why? |
| Medical Waste Disposal | 1 | 2020 | 221 | 0.04 | Why? |
| Tumor Burden | 1 | 2019 | 369 | 0.04 | Why? |
| Disease Outbreaks | 3 | 2020 | 27595 | 0.04 | Why? |
| Japan | 2 | 2021 | 6653 | 0.04 | Why? |
| Cost-Benefit Analysis | 1 | 2007 | 2259 | 0.04 | Why? |
| Vascular Access Devices | 1 | 2018 | 122 | 0.04 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.04 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.04 | Why? |
| Lower Extremity | 1 | 2021 | 593 | 0.04 | Why? |
| Multiple Trauma | 1 | 2016 | 80 | 0.04 | Why? |
| Abdominal Injuries | 1 | 2016 | 72 | 0.04 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
| Conservative Treatment | 1 | 2018 | 349 | 0.04 | Why? |
| Imaging, Three-Dimensional | 1 | 2020 | 680 | 0.04 | Why? |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2003 | 877 | 0.04 | Why? |
| Radiologists | 1 | 2021 | 873 | 0.03 | Why? |
| China | 4 | 2021 | 50654 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Health Personnel | 2 | 2020 | 29646 | 0.03 | Why? |
| Adolescent | 2 | 2020 | 86841 | 0.03 | Why? |
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2020 | 869 | 0.03 | Why? |
| Antifungal Agents | 1 | 2003 | 1828 | 0.03 | Why? |
| Ultrasonography, Interventional | 1 | 2017 | 560 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Incidental Findings | 1 | 2015 | 487 | 0.03 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.03 | Why? |
| Ultrasonography, Doppler, Color | 1 | 2010 | 107 | 0.03 | Why? |
| Sepsis | 1 | 2007 | 3517 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2019 | 17020 | 0.02 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.02 | Why? |
| Thrombosis | 1 | 2010 | 7504 | 0.02 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.02 | Why? |
| Body Mass Index | 1 | 2021 | 4306 | 0.02 | Why? |
| Acute Disease | 1 | 2020 | 6029 | 0.02 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.02 | Why? |
| Plasminogen Activators | 1 | 2005 | 16 | 0.02 | Why? |
| Urokinase-Type Plasminogen Activator | 1 | 2005 | 62 | 0.02 | Why? |
| Consensus | 1 | 2019 | 6345 | 0.02 | Why? |
| Time Factors | 1 | 2007 | 31397 | 0.02 | Why? |
| Voriconazole | 1 | 2003 | 206 | 0.01 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Triazoles | 1 | 2003 | 440 | 0.01 | Why? |
| Opportunistic Infections | 1 | 2003 | 602 | 0.01 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Prognosis | 1 | 2019 | 32490 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Pyrimidines | 1 | 2003 | 1557 | 0.01 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2019 | 15421 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Thrombolytic Therapy | 1 | 2005 | 2218 | 0.01 | Why? |
| Emergencies | 1 | 2008 | 4095 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |